On-Demand Webinar:

Fireside Chat with GlaxoSmithKline’s Ashish Gupta: The ‘New Normal’ for the Pharmaceutical Supply Chain

Watch Now
In the healthcare industry, a single supply chain holdup can mean thousands of lives put at risk. That’s why GlaxoSmithKline Pharmaceutical Supply Chain relies on Resilinc to map and monitor their supply chain, letting patients and healthcare professionals know that GlaxoSmithKline has their back even in the midst of major disruptions. Resilinc’s advanced AI solutions have helped them improve the quality of human life through helping people do more, feel better, and live longer.

In this fireside chat, special guest Ashish Gupta, the VP of Specialty Pharma Supply Chain and Strategy at GlaxoSmithKline, and Resilinc’s CEO Bindiya Vakil discussed about:

  • The lasting effects of COVID-19 on the health sector, and how GlaxoSmithKline navigated through the pandemic
  • A deep dive into how Resilinc’s AI technology has helped GlaxoSmithKline create and maintain a resilient supply chain
  • The future of GlaxoSmithKline’s risk program: a look into near-term supply chain challenges and their commitment to sustainability

Speakers

Bindiya Vakil CEO Resilinc

Bindiya Vakil

CEO & Chairman of the Board
Bindiya Vakil is CEO and founder of Resilinc and is a recognized thought leader in the area of supply chain risk management. She is a subject matter expert having worked in sourcing, materials management, and supply chain roles in the high-tech industry at companies including Flextronics, Cisco, and Broadcom.
Ashish-Gupta

Ashish Gupta

Vice President – Supply Chain & Strategy at GlaxoSmithKline
Ashish Gupta is responsible for the Supply Chain Leadership for GlaxoSmithKline Oncology, Immunology, COVID Therapies, Specialty Medicine and Respiratory Biologic medicines. Ashish Gupta’s team manages the Global supply chain planning, NPI launches, Product Lifecycle strategy and Network Strategy for the GlaxoSmithKline Specialty Pharmaceutical portfolio.